Abstract
Aim: This study was aimed at identifying the prognostic factors predicting remission in pediatric differentiated thyroid cancer (DTC) patients presenting with pulmonary metastases. Little is known about the prognostic factors in reference to pediatric DTC patients presenting with pulmonary metastases.
Methods: Fifty-three DTC patients aged ≤21 years were diagnosed with pulmonary metastases at initial presentation. The demographic and disease characteristics were compared between the patients who achieved remission and those who did not.
Results: During the median follow-up of 72 months, 38 patients became disease free, 14 patients had biochemically and/or structurally persistent disease, and one patient died due to disease progression. Patient age >15 years, presence of macronodular pulmonary metastases, and surgical methods lesser than total/near-total thyroidectomy were identified as factors associated with reduced odds of remission.
Conclusion: This study describes the disease course and depicts the disease related prognostic factors in pediatric DTC patients with pulmonary metastases.
References
1. SEER Cancer Statistics Review, 1975–2005. Bethesda: National Cancer Institute, 2008. Available at: http://seer.cancer.gov/csr/1975_2005.Search in Google Scholar
2. Zimmerman D, Hay ID, Gough IR, Goellner JR, Ryan JJ, et al. Papillary thyroid carcinoma in children and adults: long-term follow-up of patients conservatively treated at one institution during three decades. Surgery 1988;104:1157–66.Search in Google Scholar
3. Zueras VM, Blanco AM, Matarranz YR, Perez RP, Morante MC, et al. Differentiated thyroid carcinoma in childhood. An Esp Pediatr 1992;37:11–4.Search in Google Scholar
4. Lamberg BA, Karkinen-Jaaskelainen M, Franssila KO. Differentiated follicle-derived thyroid carcinoma in children. Acta Paediatr Scand 1989;78:419–25.10.1111/j.1651-2227.1989.tb11102.xSearch in Google Scholar PubMed
5. Handkiewicz-Junak D, Wloch J, Roskosz J, Krajewska J, Kropinska A, et al. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer. J Nucl Med 2007;48:879–88.10.2967/jnumed.106.035535Search in Google Scholar PubMed
6. Demidchik YE, Demidchik EP, Reiners C, Biko J, Mine M, et al, Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus. Ann Surg 2006;243:525–32.10.1097/01.sla.0000205977.74806.0bSearch in Google Scholar PubMed PubMed Central
7. Grigsby PW, Gal-or A, Michalski JM, Doherty GM. Childhood and adolescent thyroid carcinoma. Cancer 2002;95:724–9.10.1002/cncr.10725Search in Google Scholar PubMed
8. Ceccarelli C, Pacini F, Lippi F, Elisei R, Arganini M, et al. Thyroid cancer in children and adolescents. Surgery 1988;104:1143–8.Search in Google Scholar
9. Bal CS, Kumar A, Chandra P, Dwivedi SN, Mukhopadhyaya S. Is chest x-ray or high-resolution computed tomography scan of the chest sufficient investigation to detect pulmonary metastasis in pediatric differentiated thyroid cancer? Thyroid 2004;14:217–25.10.1089/105072504773297894Search in Google Scholar PubMed
10. Brink JS, van Heerden JA, McIver B, Salamao DR, Farley DR, et al. Papillary thyroid cancer with pulmonary metastases in children: long-term prognosis. Surgery 2000;128:881–7.10.1067/msy.2000.109728Search in Google Scholar PubMed
11. La Quaglia MP, Black T, Holcomb GW 3rd, Sklar C, Azizkhan RG, et al. Differentiated thyroid cancer: clinical characteristics, treatment, and outcome inpatients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children’s Cancer Group. J Pediatr Surg 2000;35:955–60.10.1053/jpsu.2000.6935Search in Google Scholar PubMed
12. Samuel AM, Rajashekharrao B, Shah DH. Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer. J Nucl Med 1998;39:1531–6.Search in Google Scholar
13. Showalter TN, Siegel BA, Moley JF, Baranski TJ, Grigsby PW. Prognostic factors in patients with well-differentiated thyroid cancer presenting with pulmonary metastasis. Cancer Biother Radiopharm 2008; 23:655–60.10.1089/cbr.2008.0501Search in Google Scholar PubMed
14. Cho SW, Choi H, Yeom GJ, Lim JA, Moon JH, et al. Long-term prognosis of differentiated thyroid cancer with lung metastasis in Korea and its prognostic factors. Thyroid 2014;24:277–86.10.1089/thy.2012.0654Search in Google Scholar PubMed PubMed Central
15. Ronga G, Filesi M, Montesano T, Di Nicola AD, Pace C, et al. Lung metastases from differentiated thyroid carcinoma. A 40 years’ experience. Q J Nucl Med Mol Imaging 2004;48:12–9.Search in Google Scholar
16. Newman KD, Black T, Heller G, Azizkhan RG, Holcomb GW 3rd, et al. Differentiated thyroid cancer: determinants of disease progression in patients <21 years of age at diagnosis. Ann Surg 2004;227:533–41.10.1097/00000658-199804000-00014Search in Google Scholar PubMed PubMed Central
17. Shapiro NL, Bhattacharyya N. Population-based outcomes for pediatric thyroid carcinoma. Laryngoscope 2005;115:337–40.10.1097/01.mlg.0000154743.71184.09Search in Google Scholar PubMed
18. Wada N, Sugino K, Mimura T, Nagahama M, Kitagawa W, et al. Pediatric differentiated thyroid carcinoma in stage I: risk actor analysis for disease free survival. BMC Cancer 2009;9:306.10.1186/1471-2407-9-306Search in Google Scholar PubMed PubMed Central
19. Pawelczak M, David R, Franklin B, Kessler M, Lam L, et al. Outcomes of children and adolescents with well-differentiated thyroid carcinoma and pulmonary metastases following 131I treatment: a systematic review. Thyroid 2010;20:1095–101.10.1089/thy.2009.0446Search in Google Scholar PubMed
20. Schlumberger M, De Vathaire F, Travagli JP, Vassal G, Lemerle J, et al. Differentiated thyroid carcinoma in childhood: long term follow-up of 72 patients. J Clin Endocrinol Metab 1987;65: 1088–94.10.1210/jcem-65-6-1088Search in Google Scholar PubMed
21. Landau D, Vini L, A’Hern R, Harmer C. Thyroid cancer in children: the Royal Marsden Hospital experience. Eur J Endocrinol 2000;36:214–20.Search in Google Scholar
22. Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab 2006;91:2892–9.10.1210/jc.2005-2838Search in Google Scholar PubMed
23. Verburg FA, Keizer B, Lips CJ, Zelissen PM, de Klerk JM. Prognostic significance of successful ablation with radioiodine of differentiated thyroid cancer patients. Eur J Endocrinol 2005;152:33–7.10.1530/eje.1.01819Search in Google Scholar PubMed
24. Mazzaferri EL, Kloos RT. Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001;86:1447–63.10.1210/jcem.86.4.7407Search in Google Scholar PubMed
25. Chow SM, Law SC, Mendenhall WM, Au SK, Yau S, et al. Differentiated thyroid carcinoma in childhood and adolescence-clinical course and role of radioiodine. Pediatr Blood Cancer 2004;42:176–83.10.1002/pbc.10410Search in Google Scholar PubMed
26. Kuo SF, Chao TC, Hsueh C, Chuang WY, Yang CH, et al. Prognosis and risk stratification in young papillary thyroid carcinoma patients. Endocr J 2008;55:269–75.10.1507/endocrj.K07E-127Search in Google Scholar
27. Arici C, Erdogan O, Altunbas H, Boz A, Melikoglu M, et al. Differentiated thyroid carcinoma in children and adolescents: clinical characteristics, treatment and outcome of 15 patients. Horm Res 2002;57:153–6.Search in Google Scholar
28. Giuffrida D, Scollo C, Pellegriti G, Lavenia G, Iurato MP, et al. Differentiated thyroid cancer in children and adolescents. J Endocrinol Invest 2002;25:18–24.10.1007/BF03343956Search in Google Scholar PubMed
29. Haveman JW, Van Tol KM, Rouwe CW, Piers DA, Plukker JT. Surgical experience in children with differentiated thyroid carcinoma. Ann Surg Oncol 2003;10:15–20.10.1245/ASO.2003.03.002Search in Google Scholar
30. Spinelli C, Bertocchini A, Antonelli A, Miccoli P. Surgical therapy of the thyroid papillary carcinoma in children: experience with 56 patients < or = 16 years old. J Pediatr Surg 2004;39:1500–5.10.1016/j.jpedsurg.2004.06.016Search in Google Scholar
31. Massimino M, Gasparini M, Ballerini E, Del Bo R. Primary thyroid carcinoma in children: a retrospective study of 20 patients. Med Pediatr Oncol 1995;24:13–7.10.1002/mpo.2950240104Search in Google Scholar
32. La Quaglia MP, Corbally MT, Heller G, Exelby PR, Brennan MF. Recurrence and morbidity in differentiated thyroid carcinoma in children. Surgery 1988;104:1149–56.Search in Google Scholar
33. Beierwaltes WH. The treatment of thyroid carcinoma with radioactive iodine. Semin Nucl Med 1978;8:79–94.10.1016/S0001-2998(78)80009-9Search in Google Scholar
34. Yeh SD, La Quaglia MP. 131I therapy for pediatric thyroid cancer. Semin Pediatr Surg 1997;6:128–33.Search in Google Scholar
35. Piekarski JD, Schiumberger M, Leclere J, Couanet D, Masselot J, et al. Chest computed tomography (CT) in patients with micronodular lung metastases of differentiated thyroid carcinoma. Int J Radiat Oncol Biol Phys 1985;11:1023–7.10.1016/0360-3016(85)90126-9Search in Google Scholar
36. Tubiana M, Lacour J, Monmer JP, Bergiron C, Gerard-Marchant R, et al. External radiotherapy and radioiodine in the treatment of 359 thyroid cancers. Br J Radiol 1975;48:894–907.10.1259/0007-1285-48-575-894Search in Google Scholar
37. Ozaki O, Ito K, Manabe Y, Nishikawa Y, Mimura T. Clinical studies on pulmonary metastases from differentiated thyroid carcinoma – characteristics of patients with pulmonary metastases which appear before thyroid operation or afterward. Nihon Geka Gakkai Zasshi 1986;87:79–83.Search in Google Scholar
38. Vaisman F, Bulzico DA, Pessoa CH, Bordallo MA, Mendonça UB, et al. Prognostic factors of a good response to initial therapy in children and adolescents with differentiated thyroid cancer. Clinics (Sao Paulo) 2011;66:281–6.10.1590/S1807-59322011000200017Search in Google Scholar
39. Ito Y, Kihara M, Takamura Y, Kobayashi K, Miya A, et al. Prognosis and prognostic factors of papillary thyroid carcinoma in patients under 20 years. Endocr J 2012;59:539–45.10.1507/endocrj.EJ12-0086Search in Google Scholar
40. Bongarzone I, Vigneri P, Mariani L, Collini P, Pilotti S, et al. RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features. Clin Cancer Res 1998;4:223–8.Search in Google Scholar
41. Nikiforov YE, Rowland JM, Bove KE, Monforte-Munoz H, Fagin JA. Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res 1997;57:1690–4.Search in Google Scholar
42. Fenton CL, Lukes Y, Nicholson D, Dinauer CA, Francis GL, et al. The ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults. J Clin Endocrinol Metab 1997;85:1170–5.Search in Google Scholar
43. Soares P, Fonseca E, Wynford-Thomas D, Sobrinho-Simoes M. Sporadic RET-rearranged papillary carcinoma of the thyroid: a subset of slow growing, less aggressive thyroid neoplasms? J Pathol 1998;185:71–8.10.1002/(SICI)1096-9896(199805)185:1<71::AID-PATH42>3.0.CO;2-SSearch in Google Scholar
44. Kumagai A, Namba H, Mitsutake N, Saenko VA, Ohtsuru A, et al. Childhood thyroid carcinoma with BRAFT1799A mutation shows unique pathological features of poor differentiation. Oncol Rep 2006;16:123–6.10.3892/or.16.1.123Search in Google Scholar
45. Faggiano A, Coulot J, Bellon N, Talbot M, Caillou B, et al. Age-dependent variation of follicular size and expression of iodine transporters in human thyroid tissue. J Nucl Med 2004;45:232–7.Search in Google Scholar
©2015 by De Gruyter
